Medicare Enrolled
Dr. Moneer Eddin, M.D.
Interventional Cardiology · Lancaster, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eddin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eddin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eddin
Dr. Moneer Eddin is an interventional cardiology specialist in Lancaster, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Eddin performed 2,063 Medicare services across 1,364 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eddin received a total of $11,273 from 44 pharmaceutical and/or device companies across 402 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eddin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ 2,063 Medicare services
$11,273 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,063
Medicare services
Bottom 46% in CA for interventional cardiology
1,364
Unique beneficiaries
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~121 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
414 | $42 | $75 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
282 | $151 | $321 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
223 | $7 | $18 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
208 | $15 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
151 | $102 | $226 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
124 | $170 | $520 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
122 | $144 | $441 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
102 | $404 | $1,120 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
102 | $55 | $173 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
92 | $91 | $239 |
| New patient office visit, complex (60-74 min) | 62 | $179 | $455 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
24 | $1,551 | $3,200 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
22 | $173 | $458 |
| Cardiac catheterization | 21 | $204 | $683 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
18 | $21 | $60 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
18 | $176 | $469 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
17 | $797 | $1,438 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
17 | $228 | $526 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $109 | $363 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
15 | $21 | $225 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
12 | $11 | $31 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.0% high complexity
44.7% medium
48.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,273
Total received (2018-2024)
Avg $1,610/year across 7 years
Top 38% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
402
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,025 (71.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,248 (28.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,172
2023
$1,377
2022
$1,360
2021
$1,837
2020
$1,654
2019
$2,091
2018
$782
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$323
Medtronic, Inc.
$280
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$214
Boston Scientific Corporation
$209
Alnylam Pharmaceuticals Inc.
$209
Merck Sharp & Dohme LLC
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Lexicon Pharmaceuticals, Inc.
$93
Kiniksa Pharmaceuticals International, plc
$83
ABIOMED
$80
AstraZeneca Pharmaceuticals LP
$74
PFIZER INC.
$73
iRhythm Technologies, Inc.
$50
Abbott Laboratories
$49
Impulse Dynamics (USA) Inc.
$43
Biosense Webster, Inc.
$39
E.R. Squibb & Sons, L.L.C.
$38
Novo Nordisk Inc
$18
SCPHARMACEUTICALS INC.
$17
Lilly USA, LLC
$17
Esperion Therapeutics, Inc.
$16
AltaThera Pharmaceuticals LLC
$8
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$4,406
Amgen Inc.
$1,015
ABIOMED
$854
Boston Scientific Corporation
$712
Merck Sharp & Dohme LLC
$490
Edwards Lifesciences Corporation
$431
PFIZER INC.
$412
AstraZeneca Pharmaceuticals LP
$386
Medtronic, Inc.
$309
Alnylam Pharmaceuticals Inc.
$309
Abbott Laboratories
$229
E.R. Squibb & Sons, L.L.C.
$220
Boehringer Ingelheim Pharmaceuticals, Inc.
$200
iRhythm Technologies, Inc.
$185
Lexicon Pharmaceuticals, Inc.
$93
Kiniksa Pharmaceuticals International, plc
$83
Regeneron Healthcare Solutions, Inc.
$77
Esperion Therapeutics, Inc.
$68
Novartis Pharmaceuticals Corporation
$59
Bardy Diagnostics, Inc.
$55
Chiesi USA, Inc.
$52
Kiniksa Pharmaceuticals, Ltd.
$48
Medtronic Vascular, Inc.
$47
SANOFI-AVENTIS U.S. LLC
$43
Kowa Pharmaceuticals America, Inc.
$43
Impulse Dynamics (USA) Inc.
$43
Janssen Pharmaceuticals, Inc
$40
Biosense Webster, Inc.
$39
Teleflex LLC
$36
CHIESI USA, INC.
$27
Amarin Pharma Inc.
$25
Cardiovascular Systems Inc.
$25
Merck Sharp & Dohme Corporation
$22
CORDIS US CORP.
$22
Cook Medical LLC
$21
Arrow International, Inc.
$18
Philips Electronics North America Corporation
$18
Novo Nordisk Inc
$18
BTG International, Inc.
$18
EKOS Corporation
$17
SCPHARMACEUTICALS INC.
$17
Lilly USA, LLC
$17
ARBOR PHARMACEUTICALS, INC.
$16
AltaThera Pharmaceuticals LLC
$8
Top 3 companies account for 55.7% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · AMPLATZER AMULET · AMVUTTRA · ANDEXXA · AVEIR · Arcalyst · Azure · BELSOMRA · BRILINTA · CAMZYOS · CHANTIX · COREVALVE EVOLUT R · CareLink · Carnation Ambulatory Monitor · Catheter - GuideLiner · Cobalt · Cook Medical AAA · Corlanor · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EKOSONIC · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · GENERAL - VASCULAR INTERVENTION · GENERAL THERAPIES · INNOVA · Impella · JARDIANCE · JOT DX · KENGREAL · KENGREAL 50MG/10ML L · LifeVest · Livalo · MANTA Vascular Closure Device · MERLIN@HOME · MITRACLIP · MYNX CONTROL · MitraClip System · NEXLETOL · NUVISION ICE CATHETER · ONPATTRO · Optimizer · PRADAXA · PRALUENT · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SELECTSECURE · Sotalol Hydrochloride · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · WAINUA · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZEPBOUND · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
3
Per 100K population
0.0
County median income
$87,760
Nearest hospital
ANTELOPE VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eddin is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eddin experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Eddin performed 414 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eddin receive payments from pharmaceutical companies?
Yes. Dr. Eddin received a total of $11,273 from 44 companies across 402 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eddin's costs compare to other interventional cardiologists in Lancaster?
Dr. Eddin's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eddin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Lancaster
Browse interventional cardiologists in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology